Mild Cognitive Impairment (MCI) Clinical Trial
Official title:
Computer-based Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment (MCI) and Mild Alzheimer's Disease (AD)
Verified date | July 2016 |
Source | University of Konstanz |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ethics Commission |
Study type | Interventional |
Age-related cognitive decline is unavoidable. However, recent results of
neuroplasticity-based research show that neuroplasticity-based training and physical
activity might have the potential to decelerate or even reverse effects of aging and
age-related cognitive impairments. Little is known whether these results also apply to
pathological processes of aging such as mild cognitive impairment (MCI) and dementia.
This multi-center study aims at investigating efficiency and feasibility of a
neuroplasticity-based auditory discrimination training and a physical fitness training for
patients suffering from mild cognitive impairment or mild Alzheimer's disease (Mini Mental
State Examination, MMSE > 19). Evaluation will include neuropsychological testing,
electroencephalography (EEG) and magnetic resonance imaging (MRI) measurements as well as
blood and liquor analyses.
Status | Completed |
Enrollment | 65 |
Est. completion date | March 2013 |
Est. primary completion date | March 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 55 Years and older |
Eligibility |
Inclusion Criteria: - focus: subjective and/or objective memory complaints with MMSE > 19 (MCI or mild Alzheimer's Disease, with stable medication for at least 3 months) - mild to moderate depression - corrected-to-normal hearing and vision - for MRI: non-magnetic metals inside the body - right handedness preferred Exclusion Criteria: - cognitive impairment/ dementia with MMSE < 20, severe psychiatric or neurological disease (current and lifetime) - physical health that does not allow physical fitness tests and trainings - benzodiazepin, tricyclic antidepressants - for MRI: magnetic metal inside the body, cardiac pacemaker etc. - for liquor: insufficient blood coagulation, insufficient brain pressure |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Germany | University of Konstanz | Konstanz | |
Germany | University of Ulm, Memory Clinic | Ulm |
Lead Sponsor | Collaborator |
---|---|
University of Konstanz | University of Ulm |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in global cognition | Average score of the two component scores "memory" and "attention / executive functions", derived from principal component analysis of 11 cognitive items (Munich verbal memory test (MVGT) encoding, MVGT long delayed free recall, free recall of the Alzheimer's Disease Assessment Scale, working memory in the Everyday Cognition Battery, Trail Making Test A and B, digit span forward and backward, digit-symbol-coding and semantic and phonematic fluency). | pre, post, 3-month follow-up | No |
Secondary | electrophysiological, MRI, blood and liquor correlates | pre, post, 3-month follow-up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00934531 -
Donepezil and the Risk of Falls in Seniors With Cognitive Impairment
|
N/A | |
Withdrawn |
NCT05033912 -
A Study of CST-2032 in Subjects With Cognitive Impairment
|
Phase 1 | |
Recruiting |
NCT02854033 -
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
|
||
Completed |
NCT01902004 -
Brain Aging and Treatment Response in Geriatric Depression
|
Phase 4 | |
Completed |
NCT01212692 -
Effects of Mental Stimulation in Patients With Mild Cognitive Impairment
|
Phase 2 | |
Recruiting |
NCT00544791 -
The Effect of Melatonin on Cognitive Function in Patients Diagnosed With Mild Cognitive Impairment
|
Phase 2 | |
Withdrawn |
NCT04055532 -
Biomarkers in Neurodegenerative Diseases
|
||
Terminated |
NCT02180529 -
The Effects of Methylphenidate on the Cognitive Function of Older People With Mild Cognitive Impairment
|
N/A | |
Completed |
NCT05108922 -
A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)
|
Phase 3 | |
Recruiting |
NCT05865340 -
To Exam the Efficacy of Oral Health and Mediterranean Diet Interventions in Preventing Cognitive Decline Among Older Adults With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT06453941 -
Yizhi Baduanjin for Patients With Cognitive Impairment
|
N/A | |
Completed |
NCT06417034 -
Hand Training Device For Cognitive Care
|
N/A | |
Completed |
NCT02110043 -
Modulation of Visual-Spatial Learning in Patients With Mild Cognitive Impairment (MCI) by tDCS
|
N/A | |
Completed |
NCT01383161 -
18-Month Study of Memory Effects of Curcumin
|
Phase 2 | |
Completed |
NCT01299766 -
Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
|
Phase 3 | |
Withdrawn |
NCT05321498 -
Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation
|
Phase 2 | |
Completed |
NCT04748666 -
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia
|
N/A | |
Recruiting |
NCT03138018 -
Aging Stereotypes and Prodromal Alzheimer's Disease
|
N/A | |
Withdrawn |
NCT01891383 -
Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
|
||
Recruiting |
NCT03448055 -
Nutritional Intervention With the Dietary Supplement, Immunocal® in MCI Patients: Promotion of Brain Health
|
N/A |